August 15, 2022
Loading...
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  >  Earnings  >  Current Article

Stellar reports higher revenues but net losses remain steady

IN THIS ARTICLE

Stellar Biotechnologies reported an increase in revenue Feb. 5, but operating expenses also rose, keeping its net losses steady at around $1.41 million for its fiscal first quarter. In the earnings release, the Port Hueneme manufacturer of proteins used in experimental therapies said it had $50,000 in revenue for the quarter ended Dec. 31, up…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.